LMNL News and Press, Liminal Biosciences Inc

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Liminal BioSciences Inc. (LMNL) is expected to report for Q3 2023

LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 26, 2023 /CNW/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") is pleased to announce tha...

LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 19, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"...

LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 15, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), is plea...

LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Sept. 12, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "...

2023-08-16 17:44:30 ET More on Liminal BioSciences Liminal to go private in buyout deal with Structured Alpha Liminal surges 77% on unsolicited buyout bid Liminal transfers to Nasdaq Capital Market, gets more time to comply with listing rule Liminal BioScienc...

LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP Canada NewsWire LAVAL, QC and CAMBRIDGE, England , Aug. 16, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announc...

Liminal BioSciences Reports Second Quarter Financial Results 2023 Canada NewsWire Provided R&D update on GPCR-targeted pipeline, including nomination of lead candidate for OXER1 antagonist program Closed June 30, 2023 with over CAD 19 million cash on hand...

2023-07-12 10:03:23 ET Gainers: Healthcare Triangle ( HCTI ) +183% . Recursion Pharmaceuticals ( RXRX ) +71% . Cadrenal Therapeutics ( CVKD ) +43% . Liminal BioSciences ( LMNL ) +40% . Eloxx Pharmaceuticals ( ELOX ) +29% . L...